Adekunle Michael Adesina, MD, PhD
Dr. Adesina's primary interest is in the clinical and molecular genetics of pediatric brain tumors with special interest in medulloblastoma. He is involved in ongoing collaborative studies with the pediatric brain tumor group of the Hematology/Oncology division. He is also a collaborator with others on the genomic profiling of embryonal pediatric tumors and the role of FoxG1 in determining susceptibility to these embryonal tumors.
Li JY, Langford LA, Adesina A, Bodhireddy SR, Wang M, Fuller GN. The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma. Brain Tumor Pathology 2012 Jan;29(1):68-72.
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.